In the latest trading session, 0.74 million Corvus Pharmaceuticals Inc (NASDAQ:CRVS) shares changed hands as the company’s beta touched 1.04. With the company’s most recent per share price at $1.76 changed hands at -$0.15 or -7.85% at last look, the market valuation stands at $86.31M. CRVS’s current price is a discount, trading about -138.07% off its 52-week high of $4.19. The share price had its 52-week low at $1.05, which suggests the last value was 40.34% up since then. When we look at Corvus Pharmaceuticals Inc’s average trading volume, we note the 3-month average coming to 226.83K.

Corvus Pharmaceuticals Inc (NASDAQ:CRVS) trade information

Instantly CRVS was in red as seen in intraday trades today. With action 13.55%, the performance over the past five days has been green. The drop to weekly highs of 2.0900 subtracted -7.85% to the stock’s daily price. The company’s shares are showing the 5-day performance at 13.55% in the green. However, in the 30-day time frame, Corvus Pharmaceuticals Inc (NASDAQ:CRVS) is 2.92% up.

Corvus Pharmaceuticals Inc (CRVS) estimates and forecasts

Data shows that the Corvus Pharmaceuticals Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 28.47% over the past 6 months, a 16.07% in annual growth rate that is considerably higher than the industry average of 13.10%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 19.89%. The 2024 estimates are for Corvus Pharmaceuticals Inc earnings to increase by 2.38%.